Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-03-14-Speech-3-356-500"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20120314.22.3-356-500"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"Diabetes is one of the most common non-communicable diseases, estimated to affect more than 32 million EU citizens, with an additional 32 million citizens suffering from impaired glucose tolerance and highly likely to progress to clinically manifest diabetes. According to estimates, the number of people living with diabetes in Europe will increase by 16.6% by 2030, in particular, as a result of the obesity epidemic and the ageing of the European population.
No cures are currently available for diabetes. The complications associated with Type 2 diabetes can be prevented through the promotion of a healthy lifestyle and, above all, early diagnosis, since often, up to 50% of all people with diabetes are unaware of their condition.
In this context, I believe that it would be justified for Member States to develop, implement and monitor national diabetes programmes aimed at health promotion, the reduction of risk factors, and the prediction, prevention, early diagnosis and treatment of diabetes, targeting both the population at large and high-risk groups in particular. With a view to achieving objectives relating to non-communicable diseases and addressing problems in the area of public health, social issues and the economy, it is no less important for the EU and the Member States to further integrate prevention and risk-factor reduction into all relevant legislative and policy fields."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples